AAAAAA

   
Results: 1-8 |
Results: 8
MANAGEMENT OF STAGE-II SEMINOMA
Authors: WARDE P GOSPODAROWICZ M PANZARELLA T CATTON C STURGEON J MOORE M JEWETT M
Citation: P. Warde et al., MANAGEMENT OF STAGE-II SEMINOMA, Journal of clinical oncology, 16(1), 1998, pp. 290-294
EFFECT OF FILGRASTIM (G-CSF) DURING CHEMOTHERAPY AND ABDOMINOPELVIC RADIATION-THERAPY IN PATIENTS WITH OVARIAN-CARCINOMA
Authors: FYLES AW MANCHUL L LEVIN W ROBERTSON JM STURGEON J TSUJI D
Citation: Aw. Fyles et al., EFFECT OF FILGRASTIM (G-CSF) DURING CHEMOTHERAPY AND ABDOMINOPELVIC RADIATION-THERAPY IN PATIENTS WITH OVARIAN-CARCINOMA, International journal of radiation oncology, biology, physics, 41(4), 1998, pp. 843-847
RISK OF 2ND MALIGNANT NEOPLASMS AMONG LONG-TERM SURVIVORS OF TESTICULAR CANCER
Authors: TRAVIS LB CURTIS RE STORM H HALL P HOLOWATY E VANLEEUWEN FE KOHLER BA PUKKALA E LYNCH CF ANDERSSON M BERGFELDT K CLARKE EA WIKLUND T STOTER G GOSPODAROWICZ M STURGEON J FRAUMENI JF BOICE JD
Citation: Lb. Travis et al., RISK OF 2ND MALIGNANT NEOPLASMS AMONG LONG-TERM SURVIVORS OF TESTICULAR CANCER, Journal of the National Cancer Institute, 89(19), 1997, pp. 1429-1439
RESOURCE IMPLICATIONS OF PALLIATIVE CHEMOTHERAPY FOR OVARIAN-CANCER
Authors: DOYLE C STOCKLER M PINTILIE M PANESAR P WARDE P STURGEON J OZA AM
Citation: C. Doyle et al., RESOURCE IMPLICATIONS OF PALLIATIVE CHEMOTHERAPY FOR OVARIAN-CANCER, Journal of clinical oncology, 15(3), 1997, pp. 1000-1007
ISSUES IN THE MANAGEMENT OF STAGE-I TESTICULAR SEMINOMA
Authors: WARDE P GOSPODAROWICZ M PANZARELLA T MURPHY T CATTON C STURGEON J MOORE M JEWETT M
Citation: P. Warde et al., ISSUES IN THE MANAGEMENT OF STAGE-I TESTICULAR SEMINOMA, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 156-156
COST-UTILITY ANALYSIS OF PACLITAXEL IN COMBINATION WITH CISPLATIN FORPATIENTS WITH ADVANCED OVARIAN-CANCER
Authors: ORTEGA A DRANITSARIS G STURGEON J SUTHERLAND H OZA A
Citation: A. Ortega et al., COST-UTILITY ANALYSIS OF PACLITAXEL IN COMBINATION WITH CISPLATIN FORPATIENTS WITH ADVANCED OVARIAN-CANCER, Gynecologic oncology, 66(3), 1997, pp. 454-463
BENEFIT OF PALLIATIVE SURGERY FOR BOWEL OBSTRUCTION IN ADVANCED OVARIAN-CANCER
Authors: JONG P STURGEON J JAMIESON CG
Citation: P. Jong et al., BENEFIT OF PALLIATIVE SURGERY FOR BOWEL OBSTRUCTION IN ADVANCED OVARIAN-CANCER, CAN J SURG, 38(5), 1995, pp. 454-457
HIGH-DOSE METHOTREXATE FOR GESTATIONAL TROPHOBLASTIC DISEASE
Authors: ELIT L COVENS A OSBORNE R GERULATH A MURPHY J ROSEN B STURGEON J
Citation: L. Elit et al., HIGH-DOSE METHOTREXATE FOR GESTATIONAL TROPHOBLASTIC DISEASE, Gynecologic oncology, 54(3), 1994, pp. 282-287
Risultati: 1-8 |